Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.
Industry, Sector and Symbol:
- 50 Day Moving Avg: $30.71
- 200 Day Moving Avg: $22.61
- 52 Week Range: $8.78 - $33.13
Sales & Book Value:
- Trailing P/E Ratio: 48.97
- P/E Growth: 0.00
- Annual Revenue: $203.35 million
- Price / Sales: N/A
- Book Value: $5.13 per share
- Price / Book: 5.56
- Average Volume: 3,273 shs.
- Short Ratio: 0.62
Frequently Asked Questions for Evotec AG (NASDAQ:EVTCY)
What is Evotec AG's stock symbol?
Evotec AG trades on the NASDAQ under the ticker symbol "EVTCY."
Who are some of Evotec AG's key competitors?
Some companies that are related to Evotec AG include Bed Bath & Beyond (BBBY), Investors Bancorp (ISBC), Kaz Minerals Plc (KZMYY), Proofpoint (PFPT), Healthcare Services Group (HCSG), GrubHub (GRUB), ICAP plc (IAPLY), Cotiviti Holdings (COTV), Wendy's Company (The) (WEN), Antero Midstream GP LP (AMGP), ViaSat (VSAT), Ellie Mae (ELLI), Schneider National (SNDR), SAIPEM NPV(POST CONS) (SAPMF), Clovis Oncology (CLVS), Acerinox Sa (ANIOY), BGC Partners (BGCP) and Cracker Barrel Old Country Store (CBRL).
Who are Evotec AG's key executives?
Evotec AG's management team includes the folowing people:
- Wolfgang Plischke, Chairman of the Supervisory Board
- Werner Lanthaler, Chief Executive Officer, Member of the Management Board
- Bernd Hirsch, Vice Chairman of the Supervisory Board
- Enno Spillner, Chief Financial Officer, Member of the Management Board
- Mario Polywka, Chief Operating Officer, Member of the Management Board
- Cord Dohrmann, Chief Scientific Officer, Member of the Management Board
- Claus T. Braestrup M.D., Member of the Supervisory Board
- Paul L. Herrling Ph.D., Member of the Supervisory Board
- Iris Loew-Friedrich, Member of the Supervisory Board
- Elaine Sullivan, Member of the Supervisory Board
How do I buy Evotec AG stock?
Shares of Evotec AG can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Evotec AG's stock price today?
MarketBeat Community Rating for Evotec AG (NASDAQ EVTCY)MarketBeat's community ratings are surveys of what our community members think about Evotec AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Evotec AG stock can currently be purchased for approximately $28.50.
Consensus Ratings for Evotec AG (NASDAQ:EVTCY) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 2 Hold Ratings|
|Consensus Rating:||Hold (Score: 1.67)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Evotec AG (NASDAQ:EVTCY)
(Data available from 7/25/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|7/12/2017||DZ Bank AG||Reiterated Rating||Sell||Medium|
|6/6/2017||Berenberg Bank||Downgrade||Buy -> Hold||Low|
|5/3/2017||Deutsche Bank AG||Reiterated Rating||Neutral||Low|
Earnings History for Evotec AG (NASDAQ:EVTCY)Earnings History by Quarter for Evotec AG (NASDAQ EVTCY)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/28/2017||Q4 2016||$0.32||$47.36 million||View||N/A|
|11/10/2016||9/30/2016||($0.02)||$0.15||$42.79 million||$50.41 million||View||N/A|
|11/10/2015||Q3 2015||$0.02||($0.04)||$37.05 million||$36.98 million||View||N/A|
|8/12/2015||Q2 2015||$0.02||$0.05||$38.43 million||$36.97 million||View||N/A|
|5/12/2015||Q1 2015||$0.02||($0.02)||$24.54 million||$24.04 million||View||N/A|
Earnings Estimates for Evotec AG (NASDAQ:EVTCY)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Evotec AG (NASDAQ:EVTCY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Evotec AG (NASDAQ:EVTCY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Evotec AG (NASDAQ:EVTCY)
Latest Headlines for Evotec AG (NASDAQ:EVTCY)
Evotec AG (EVTCY) Chart for Tuesday, July, 25, 2017